Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Penicillin Acylase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1087350C reveals a breakthrough enzymatic method for beta-lactam antibiotics, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN105732663B reveals a novel activator boosting 6-APA yield. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN108949736B reveals a novel PGA mutant for cephradine synthesis, offering superior Vs/Vh ratios and reduced hydrolysis for efficient API manufacturing.
Patent CN101003822A reveals immobilized enzyme hydrolysis for high-purity D-amino acids. Offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103074409A details a novel enzymatic resolution method for high-purity halogenated alpha-amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111051506A discloses engineered PGA variants for efficient insulin dimer deprotection. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN101631872B reveals a novel process for beta-lactam compounds eliminating solid isolation. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN1063491C details a low-temperature enzymatic route for cephalosporins, offering reduced byproducts and simplified pH control for scalable manufacturing.